APIA, Samoa, Sept. 24, 2025 /PRNewswire/ — Phemex, the most efficient crypto exchange, has announced a limited-time promotion designed to make fiat onboarding and large-scale deposits more accessible and cost-effective. The campaign introduces reduced fees for both new users in the European Economic Area (EEA) and high-volume depositors worldwide, reinforcing the platform’s commitment to efficient digital asset trading.
Key Incentives:
The promotion runs from September 19 to October 20, 2025, with discounts applied automatically during the deposit process.
By easing both entry-level and large-scale funding, this campaign complements Phemex’s established fiat trading infrastructure, which provides fast, reliable transactions for retail, VIP, and institutional clients, supported by trusted gateways, high transaction limits, and some of the most competitive fees in the industry.
About Phemex
Founded in 2019, Phemex is the most efficient crypto exchange trusted by over 6 million traders worldwide. The platform offers spot and derivatives trading, copy trading, and wealth management products that combine seamless functionality with institutional-grade security. Known for its reliability and innovative edge, Phemex stands out for prioritizing user experience and transparency in an industry where trust is essential.
For more information, please visit: https://phemex.com/
Photo – https://mma.prnewswire.com/media/2780922/image.jpg
View original content:https://www.prnewswire.co.uk/news-releases/phemex-unveils-promotion-to-cut-costs-on-fiat-to-crypto-deposits-globally-302565781.html
Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…
•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…
Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…
June 05, 2026 19:30 ET | Source: Oban BioPharma, Inc. STAMFORD, Conn., June 05, 2026…
Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…
June 05, 2026 20:13 ET | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…